Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Center For Human Genetics And Laboratory Diagnostics, |
RCV000678979 | SCV000805195 | uncertain significance | Long QT syndrome 3 | 2018-06-15 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001692259 | SCV001912000 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001692259 | SCV002468362 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Roden Lab, |
RCV004698511 | SCV005200411 | likely benign | Brugada syndrome 1 | criteria provided, single submitter | research | We classified this variant using data from the calibrated functional assay 'ParSE-seq' (PMID: 37732247), population data, and in silico data within the ACMG v3 framework (PMID: 25741868)The SCN5A variant, 3-38586048-A-G was evaluated for association with the loss-of-function condition Brugada Syndrome.This Variant had an AF of 0 in gnomAD v3The in silico predictor SpliceAI scored the variant as 0; normal <0.2, likely damaging >0.5.Using the functional RNA-splicing assay, ParSE-seq, the variant was evaluated to have no impact on splicing (BS3_strong) following the Brnich et al. calibration framework (PMID: 31892348). We do not apply benign splicing functional data to missense variants. In aggregate, we therefore classify this variant as LB using these collective data. |